{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:42:12Z","timestamp":1785526932870,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"DOI":"10.1007\/s00253-026-13887-x","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:34:53Z","timestamp":1780054493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SphB1 export system for antigen presentation to the respiratory tract by a live pertussis vaccine"],"prefix":"10.1007","volume":"110","author":[{"given":"Lazara Elena","family":"Santiesteban-Lores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Raze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Tardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Debrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Coutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Locht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"13887_CR1","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1128\/IAI.73.7.4295-4301.2005","volume":"73","author":"S Alonso","year":"2005","unstructured":"Alonso S, Willery E, Renauld-Mongenie G, Locht C (2005) Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier. Infect Immun 73:4295\u20134301","journal-title":"Infect Immun"},{"key":"13887_CR2","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1128\/iai.58.6.1518-1526.1990","volume":"58","author":"R Antoine","year":"1990","unstructured":"Antoine R, Locht C (1990) Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin. Infect Immun 58:1518\u20131526","journal-title":"Infect Immun"},{"key":"13887_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6271","volume":"5","author":"C Baud","year":"2014","unstructured":"Baud C, Gu\u00e9rin J, Petit E, Lesne E, Dupr\u00e9 E, Locht C, Jacob-Dubuisson F (2014) Translocation path of a substate protein through its Omp85 transporter. Nat Commun 5:5271","journal-title":"Nat Commun"},{"key":"13887_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01398","volume":"8","author":"PD Bittner-Eddy","year":"2017","unstructured":"Bittner-Eddy PD, Fischer LA, Tu AA, Allman DA, Costalonga M (2017) Discriminating between interstitial and circulating leukocytes in tissues of the murine oral mucosa avoiding nasal-associated lymphoid tissue contamination. Front Immunol 8:1398","journal-title":"Front Immunol"},{"key":"13887_CR5","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/mi.2016.28","volume":"10","author":"D Christensen","year":"2017","unstructured":"Christensen D, Mortensen R, Rosenkrands I, Dietrich J, Andersen P (2017) Vaccine-induced Th17 cells are established as resident memory cells in the lung and promote local IgA responses. Mucosal Immunol 10:260\u2013270","journal-title":"Mucosal Immunol"},{"key":"13887_CR6","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1073\/pnas.0400291101","volume":"101","author":"B Clantin","year":"2004","unstructured":"Clantin B, Hodak H, Willery E, Locht C, Jacob-Dubuisson F, Villeret V (2004) The crystal structure of the filamentous hemagglutinin secretion domain and its implications for the two-partner secretion pathway. Proc Natl Acad Sci U S A 101:6194\u20136199","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13887_CR7","doi-asserted-by":"crossref","unstructured":"Clark-Curtiss JE, Curtiss R 3rd (2018) Salmonella vaccines: conduits for protective antigens. J Immunol 200:39\u201348","DOI":"10.4049\/jimmunol.1600608"},{"key":"13887_CR8","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1128\/IAI.69.9.5440-5446.2001","volume":"69","author":"I Coppens","year":"2001","unstructured":"Coppens I, Alonso S, Antoine R, Jacob-Dubuisson F, Renauld-Mong\u00e9nie G, Jakobs E, Locht C (2001) Production of Neisseria meningitidis transferrin-binding protein B by recombinant Bordetella pertussis. Infect Immun 69:5440\u20135446","journal-title":"Infect Immun"},{"key":"13887_CR9","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1093\/emboj\/20.18.5040","volume":"20","author":"L Coutte","year":"2001","unstructured":"Coutte L, Antoine R, Drobecq H, Locht C, Jacob-Dubuisson F (2001) Subtilisin-like autotransporter serves as maturation protease in a bacterial secretion pathway. EMBO J 20:5040\u20135048","journal-title":"EMBO J"},{"key":"13887_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2958.2003.03573.x","volume":"49","author":"L Coutte","year":"2003","unstructured":"Coutte L, Willery E, Antoine R, Drobecq H, Locht C, Jacob-Dubuisson F (2003) Surface anchoring of bacterial subtilisin important for maturation function. Mol Microbiol 49:529\u2013539","journal-title":"Mol Microbiol"},{"key":"13887_CR11","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1016\/j.vaccine.2022.09.075","volume":"40","author":"CB Creech","year":"2022","unstructured":"Creech CB, Jimenez-Truque N, Kown N, Sokolow K, Brady EJ, Yoder S, Solovay K, Rubin K, Noviello S, Hensel E, Selamawi S, Bakare A, Makowski M, Lu K (2022) Safety and immunogenicity of live, attenuated intranasal Bordetella pertussis vaccine (BPZE1) in healthy adults. Vaccine 40:6740\u20136746","journal-title":"Vaccine"},{"key":"13887_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","volume":"584","author":"N De Bert","year":"2020","unstructured":"De Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, Chng MHY, Lin M, Tan N, Linster M, Chia WN, Chen MIC, Wang LF, Ooi EE, Kalimuddin S, Tam-byah PA, Low JGH, Tan YJ, Bertoletti A (2020) SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 584:457\u2013462","journal-title":"Nature"},{"key":"13887_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-00270-8","volume":"6","author":"V Dubois","year":"2021","unstructured":"Dubois V, Chatagnon J, Thiriard A, Bauderlique-Le Roy H, Debrie AS, Coutte L, Locht C (2021) Suppression of mucosal Th17 memory response by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage. npj Vaccines 6:6","journal-title":"npj Vaccines"},{"issue":"6577","key":"13887_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/381090a0","volume":"381","author":"P Emsley","year":"1996","unstructured":"Emsley P, Charles IG, Fairweather NF, Isaacs NW (1996) Structure of Bordetella pertussis virulence factor p.69 pertactin. Nature 381(6577):90\u201392","journal-title":"Nature"},{"key":"13887_CR15","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1128\/iai.62.11.4727-4738.1994","volume":"62","author":"RC Fernandez","year":"1994","unstructured":"Fernandez RC, Weiss AA (1994) Cloning and sequencing of a Bordetella pertussis serum resistant locus. Infect Immun 62:4727\u20134738","journal-title":"Infect Immun"},{"key":"13887_CR16","doi-asserted-by":"crossref","unstructured":"Ferretti AP, Kula T, Wang Y, Nguyen DMV, Weinheimer A, Dunlap GS, Xu Q, Nabilsi N, Perullo CR, Cristofaro AW, Whitton HJ, Virbasius A, Olivier KJ Jr, Buckner LR, Alistar AT, Whitman ED, Bertino SA, Chattopadhyay S, MacBeath G (2020) Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein. Immunity 53:1095\u20131107","DOI":"10.1016\/j.immuni.2020.10.006"},{"key":"13887_CR17","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1128\/IAI.66.8.3985-3989.1998","volume":"66","author":"TM Finn","year":"1998","unstructured":"Finn TM, Amsbaugh DF (1998) Vag8, a Bordetella pertussis bvg-regulated protein. Infect Immun 66:3985\u20133989","journal-title":"Infect Immun"},{"key":"13887_CR18","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1365-2958.1995.tb02425.x","volume":"16","author":"TM Finn","year":"1995","unstructured":"Finn TM, Stevens LA (1995) Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. Mol Microbiol 16:625\u2013634","journal-title":"Mol Microbiol"},{"key":"13887_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.micinf.2018.01.005","volume":"20","author":"PN Frantz","year":"2018","unstructured":"Frantz PN, Teeravechyan S, Tangy F (2018) Measles-derived vaccines to prevent emerging viral diseases. Microbes Infect 20:493\u2013500","journal-title":"Microbes Infect"},{"key":"13887_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2025.101211","volume":"6","author":"D Gbesemete","year":"2025","unstructured":"Gbesemete D, Ramasamy MN, Ibrahim M, Hill AR, Raud L, Ferreira DM, Guy J, Dale AP, Laver JR, Coutinho T, Faust SN, Reed TAN, Babbage G, Weissfeld L, Lang W, Locht C, Samal V, Goldstein P, Solovay K, Rubin K, Noviello S, Read RC (2025) Efficacy, immunogenicity, and safety of the live attenuated nasal pertussis vaccine, BPZE1, in the UK: a randomised, placebo-controlled, phase 2b trial using a controlled human infection model with virulent Bordetella pertussis. Lancet Microbe 6:101211","journal-title":"Lancet Microbe"},{"key":"13887_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1046\/j.1365-2958.1998.00970.x","volume":"29","author":"S Gu\u00e9din","year":"1998","unstructured":"Gu\u00e9din S, Willery E, Locht C, Jacob-Dubuisson F (1998) Evidence that a globular conformation is not compatible with FhaC-mediated secretion of the Bordetella pertussis filamentous haemagglutinin. Mol Microbiol 29:763\u2013774","journal-title":"Mol Microbiol"},{"key":"13887_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/IAI.00795-07","volume":"76","author":"SY Ho","year":"2008","unstructured":"Ho SY, Chua SQ, Foo DG, Locht C, Chow VT, Poh CL, Alonso S (2008) Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates. Infect Immun 76:111\u2013119","journal-title":"Infect Immun"},{"key":"13887_CR23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1128\/jcm.17.5.781-786.1983","volume":"17","author":"A Imaizumi","year":"1983","unstructured":"Imaizumi A, Suzuki Y, Ono S, Sato H, Sato Y (1983) Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I. J Clin Microbiol 17:781\u2013786","journal-title":"J Clin Microbiol"},{"key":"13887_CR24","doi-asserted-by":"crossref","unstructured":"Jahnmatz M, Richert L, Al-Tawil N, Storsaeter J, Colin C, Bauduin C, Thalen M, Solovay K, Rubin K, Mielcarek N, Thorstensson R, Locht C, the BPZE1 study team (2020) Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomized, placebo-controlled dose-escalation study. Lancet Infect Dis 20:1290-1301","DOI":"10.1016\/S1473-3099(20)30274-7"},{"key":"13887_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1046\/j.1365-2958.2001.02598.x","volume":"42","author":"AV Kajava","year":"2001","unstructured":"Kajava AV, Cheng N, Cleaver R, Kessel M, Simon MN, Willery E, Jacob-Dubuisson F, Locht C, Steven AC (2001) Beta-helix model for the filamentous haemagglutinin adhesin of Bordetella pertussis and elated bacterial secretory proteins. Mol Microbiol 42:279\u2013292","journal-title":"Mol Microbiol"},{"key":"13887_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059198","volume":"8","author":"H Kammoun","year":"2013","unstructured":"Kammoun H, Roux X, Raze D, Debrie AS, De Filette M, Ysenbaert T, Mielcarek N, Saelens X, Fiers W, Locht C (2013) Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e. PLoS One 8:e59198","journal-title":"PLoS One"},{"key":"13887_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01350-24","volume":"99","author":"V Karl","year":"2015","unstructured":"Karl V, Hofmann M, Thimme R (2015) Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination. J Virol 99:e0135024","journal-title":"J Virol"},{"key":"13887_CR28","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0140-6736(22)02644-7","volume":"401","author":"C Keech","year":"2023","unstructured":"Keech C, Miller VE, Rizzardi B, Hoyle C, Pryor MJ, Ferrand J, Solovay K, Thalen M, Noviello S, Goldstein P, Gorringe A, Cavell B, He Q, Barkoff AM, Rubin K, Locht C (2023) Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomized, double-blind, phase 2b trial. Lancet 401:843\u2013855","journal-title":"Lancet"},{"key":"13887_CR29","doi-asserted-by":"publisher","first-page":"5502","DOI":"10.1016\/j.vaccine.2011.05.052","volume":"29","author":"R Li","year":"2011","unstructured":"Li R, Lim A, Ow STL, Phoon MC, Locht C, Chow VT, Alonso S (2011) Development of live attenuated Bordetella pertussis stains expressing the universal influenza vaccine candidate M2e. Vaccine 29:5502\u20135511","journal-title":"Vaccine"},{"key":"13887_CR30","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3390\/vaccines3040940","volume":"3","author":"IY Lin","year":"2015","unstructured":"Lin IY, Van TT, Smooker PM (2015) Live-attenuated bacterial vectors: tools for vaccine and therapeutic agent delivery. Vaccines 3:940\u2013972","journal-title":"Vaccines"},{"key":"13887_CR31","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/infdis\/jiab543","volume":"224","author":"Z Lu","year":"2021","unstructured":"Lu Z, Laing ED, Pena DaMata J, Pohida K, Tso MS, Samuels EC, Epsi NJ, Dorjbal B, Lake C, Richard SA, Maves RC, Lindholm DA, Rozman JS, English C, Huprikar N, Mende K, Colombo RE, Colombo CJ, Broder CC, Ganesan A, Lanteri CA, Agan BK, Tribble D, Simons MP, Dalgard CL, Blair PW, Chenoweth J, Pollett SD, Snow AL, Burgess TH, Malloy AMW, EPICC COVID-19 Cohort Study Group (2021) Durability of SARS-CoV-2-specific T-cell responses at 12 months postinfection. J Infect Dis 224:2010\u20132019","journal-title":"J Infect Dis"},{"key":"13887_CR32","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1172\/JCI63689","volume":"122","author":"KK McKinstry","year":"2012","unstructured":"McKinstry KK, Strutt TM, Kuang Y, Brown DM, Sell S, Dutton RW, Swain SL (2012) Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. J Clin Invest 122:2847\u20132856","journal-title":"J Clin Invest"},{"key":"13887_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.micres.2005.02.007","volume":"160","author":"B Middendorf","year":"2005","unstructured":"Middendorf B, Stubs D, Guiso N, Deppisch H, Gross R, Fuchs TM (2005) Phg, a novel member of the autotransporter family present in Bordetella species. Microbiol Res 160:329\u2013336","journal-title":"Microbiol Res"},{"key":"13887_CR34","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nbt0598-454","volume":"16","author":"N Mielcarek","year":"1998","unstructured":"Mielcarek N, Riveau G, Remoue F, Antoine R, Capron A, Locht C (1998) Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis. Nat Biotechnol 16:454\u2013457","journal-title":"Nat Biotechnol"},{"key":"13887_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020065","volume":"2","author":"N Mielcarek","year":"2006","unstructured":"Mielcarek N, Debrie AS, Raze D, Bertout J, Rouanet C, Ben Younes A, Creusy C, Engle J, Goldman WE, Locht C (2006) Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2:e65","journal-title":"PLoS Pathog"},{"key":"13887_CR36","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105938","volume":"39","author":"Y Peng","year":"2020","unstructured":"Peng Y, Du N, Lei Y, Dorje S, Qi J, Luo T, Gao GF, Song H (2020) Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design. EMBO J 39:e105938","journal-title":"EMBO J"},{"key":"13887_CR37","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.1073\/pnas.93.15.7944","volume":"93","author":"G Renauld-Mong\u00e9nie","year":"1996","unstructured":"Renauld-Mong\u00e9nie G, Mielcarek N, Cornette J, Schacht AM, Capron A, Riveau G, Locht C (1996) Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis. Proc Natl Acad Sci U S A 93:7944\u20137949","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13887_CR38","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0264-410X(01)00380-2","volume":"20","author":"N Reveneau","year":"2002","unstructured":"Reveneau N, Alonso S, Jacob-Dubuisson F, Mercenier A, Locht C (2002) Tetanus toxin fragment C-specific priming by intranasal infection with recombinant Bordetella pertussis. Vaccine 20:926\u2013933","journal-title":"Vaccine"},{"key":"13887_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00912-22","volume":"13","author":"G Roy","year":"2022","unstructured":"Roy G, Antoine R, Schwartz A, Slupek S, Rivera-Millot A, Boudvillain M, Jacob-Dubuisson F (2022) Posttranscriptional regulation by copper with a new upstream open reading frame. Mbio 13:e0091222","journal-title":"Mbio"},{"key":"13887_CR40","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/nbt1183-784","volume":"1","author":"R Simon","year":"1983","unstructured":"Simon R, Priefer U, P\u00fchler A (1983) A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram negative bacteria. Biotechnology 1:784\u2013791","journal-title":"Biotechnology"},{"key":"13887_CR41","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1038\/s41385-018-0073-9","volume":"11","author":"L Solans","year":"2018","unstructured":"Solans L, Debrie AS, Borkner L, Aguilo N, Thiriard A, Coutte L, Uranga S, Trottein F, Martin C, Mills KHG, Locht C (2018) IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine. Mucosal Immunol 11:1753\u20131762","journal-title":"Mucosal Immunol"},{"key":"13887_CR42","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1016\/j.vaccine.2021.04.014","volume":"39","author":"L Solans","year":"2021","unstructured":"Solans L, Debrie AS, Coutte L, Locht C (2021) Construction and evaluation of a pertactin-deficient live attenuated pertussis vaccine candidate BPZE1 derivative. Vaccine 39:2843\u20132849","journal-title":"Vaccine"},{"key":"13887_CR43","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1099\/00221287-63-2-211","volume":"63","author":"DW Stainer","year":"1970","unstructured":"Stainer DW, Scholte MJ (1970) A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol 63:211\u2013220","journal-title":"J Gen Microbiol"},{"key":"13887_CR44","doi-asserted-by":"crossref","unstructured":"Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF, Snapper SB, Barletta RG, Jacobs WR Jr, Bloom BR (1991) New use of BCG for recombinant vaccines. Nature 351:456\u2013460","DOI":"10.1038\/351456a0"},{"key":"13887_CR45","doi-asserted-by":"crossref","unstructured":"Tan AT, Linster M, Tan CW, Le Bert N, Chia WN, Kunasegaran K, Zhuang Y, Tham CYL, Chia A, Smith GJD, Young B, Kalimuddin S, Low JGH, Lye D, Wang LF, Bertoletti (2021) Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients. Cell Rep 34:108728","DOI":"10.1016\/j.celrep.2021.108728"},{"key":"13887_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083449","volume":"9","author":"R Thorstensson","year":"2014","unstructured":"Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergstr\u00f6m J, Ljungman M, T\u00f6rner A, Wehlin L, Van Broekhoven A, Bospman F, Debrie AS, Mielcarek N, Locht C (2014) A phase I clinical study of a live attenuated Bordetella pertussis vaccine \u2013 BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One 9:e83449","journal-title":"PLoS One"},{"key":"13887_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/221235a0","volume":"221","author":"CS Wright","year":"1969","unstructured":"Wright CS, Alden RA, Kraut J (1969) Structure of subtilisin BPN\u2019 at 2.5 Angstr\u00f6m resolution. Nature 221:235\u2013242","journal-title":"Nature"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-026-13887-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-026-13887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-026-13887-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:06:08Z","timestamp":1785521168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-026-13887-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13887"],"URL":"https:\/\/doi.org\/10.1007\/s00253-026-13887-x","relation":{},"ISSN":["1432-0614"],"issn-type":[{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the animal experiments were carried out in accordance with the guidelines of the French Ministry of Research, and the protocols were approved by the Ethical Committees of the Region Nord Pas de Calais and the French Ministry of Research (agreement numbers APAFIS #20717-2019052015506229 and APAFIS #36244-2022031617542892).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"233"}}